Our mission

To help people realize their full potential with
innovative, scalable, and trusted experiences.


There is a tremendous amount of unmet need in the healthcare system and disruptive solutions that empower consumers to become active participants in their own care have the best chance at succeeding. At Allurion, we value design principles that are driven by consumer preference and a company culture that prioritizes openness, transparency, and collaboration.

Our values

Ethics first
Ethics first
Openness and transparency
Openness and transparency
Scientific validation
Scientific validation
Data driven decision making
Data driven decision making
Employee fulfillment
Employee fulfillment

Our Story

Allurion Technologies was founded in 2009, during Sammy and Shantanu's second year at Harvard Medical School, when they began to rethink popular perceptions of weight loss. To better understand the journeys of people who were overweight or struggling with obesity, Sammy and Shantanu did something out of the ordinary: they listened to their patients’ stories. Now, Allurion is transforming thousands of lives around the world.

Sammy and Shantanu realized that overweight individuals were frustrated by the ineffectiveness of dieting, but they were afraid of the invasiveness or simply could not afford weight loss surgery. More importantly, their patients were asking for something easy and convenient, without the medical complexity that accompanies other weight loss therapies. As they started researching solutions, they imagined what would become Allurion’s 360-degree weight loss platform - the Elipse Program.

The Elipse Program has been used by thousands of individuals and is rapidly becoming the weight loss program of choice. It is currently available across Europe and the Middle East.
Today, Allurion retains the original vision of its founders: to help people realize their full potential with innovative, scalable, and trusted experiences.

Read the full storySee less
Dr. Shantanu Gaur Chief Executive Officer
Dr. Samuel Levy President
Ram Chuttani, MD Chief Medical Officer
Benoit Chardon Vice President - Sales and Marketing
Camillo Docimo Executive Director of Southern Europe Sales & International Business Development
Hubertus Schulze Zumkley Director of Sales Northern Europe
Nidal Naji Regional Director GCC Asia PAC
Javier Ibanez Executive Director of Sales LATAM
Julia Wilkins Director of Finance
Ken Malomo Director of Clinical Affairs
Chris Tomosivitch Chief Financial Officer
Bruce Horwitz Director of Intellectual Property
Kelly Houston Director of Human Resources
Bill Burke Director of Operations
Wayne Medeiros Director of Quality Assurance
John Genereux Director of Research and Development
  • image
    • Michael Davin

    As Cynosure’s Chairman, President and Chief Executive Officer from 2003 to 2017, Michael Davin oversaw sales growth from $20 million to $430 million including significant international expansion, led the company’s initial public offering and listing on the NASDAQ and executed key acquisitions. Under his leadership, Cynosure achieved compound annual revenue growth of more than 20 percent and became one of the largest and most profitable companies in the aesthetic industry. Cynosure was sold to Hologic for $1.65 billion in March 2017.

  • image
    • Todd Zavodnick

    Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry and is currently Dermavant’s Chief Executive Officer. Prior to joining Dermavant, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He previously served in global leadership roles at ZELTIQ Aesthetics prior to the company’s acquisition by Allergan, at Galderma Laboratories where he was president and general manager of North America, and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation.

  • image
    • Gail Zauder

    Gail Zauder is the Managing Partner of Elixir Advisors, a financial and strategic advisory firm she founded in 2002. She is recognized as one of the foremost advisors to creative entrepreneurs and companies in the luxury goods, beauty, and retail and apparel sectors. Prior to founding Elixir, Ms. Zauder was a Managing Director at Credit Suisse First Boston where she was global head of the Luxury Goods Investment Banking Group. During her years in Investment Banking, Ms. Zauder has been involved in more than 100 merger and acquisition and financing transactions representing over $35 billion in value.

  • image
    • Krishna Gupta

    Krishna Gupta is the Founder and Managing Partner of Romulus Capital. A venture capital firm that focuses on building, not betting on, science- and technology-enabled companies. Mr. Gupta has been involved with Allurion since 2010, and Romulus led Allurion’s $27M Series C funding. Under Mr. Gupta’s leadership, Romulus has built a powerful portfolio of innovative companies and a global investor base from more than 20 countries. Mr. Gupta has extensive experience helping high-growth companies scale to become category leaders.

  • image
    • Samuel Levy

    Samuel Levy co-founded Allurion Technologies with Shantanu Gaur in 2009. Samuel graduated summa cum laude with a B.S. in Molecular Biophysics and Biochemistry from Yale College and with an M.D. from Harvard Medical School. He was a Fulbright Scholar to France and served pharmaceutical and medical products clients as a consultant at McKinsey & Company.

  • image
    • Shantanu Gaur

    Shantanu Gaur co-founded Allurion Technologies with Samuel Levy in 2009. Shantanu completed his A.B. in Biology from Harvard College, where he graduated summa cum laude with election to Phi Beta Kappa. Shantanu received his M.D. from Harvard Medical School.

Nezam Afdhal, MD
Jordan Busch, MD, FACP
Ram Chuttani, MD
Daniel Jones, MD, MS, FACS
Elisabeth Mathus-Vliegen, MD, PhD
John Morton, MD, MPH, FACS, FASMBS
Bruce Schirmer, MD
Harold Solomon, MD
Peter D. Siersma, MD, PhD, FASGE, FACG
Richard Rothstein, MD
In memoriam: George Blackburn, MD, PhD (1936-2017)


Do well by doing good.
Join our fast growing team.

See our open positions


Allurion Technologies Offices:

Headquarters - Boston
11 Huron Dr
Natick, MA 01760
United States of America

11 rue de Téhéran,
75008, Paris

Prime Tower, Floor 29, Office 36,
Business Bay,
Dubai, UAE

Contact us